RxSearch

NDC properties for "adalimumab-adbm Pen 40 MG/0.8 ML Starter Pack - Psoriasis/Uveitis (4 count)" (RxCUI 2640900)

About this data

The tables show NDC propoerties for adalimumab-adbm Pen 40 MG/0.8 ML Starter Pack - Psoriasis/Uveitis (4 count) with the RxCUI 2640900

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product

Details for adalimumab-adbm Pen 40 MG/0.8 ML Starter Pack - Psoriasis/Uveitis (4 count) (RxCUI 2640900)

BLABLA761058
MMSL_CODEMTH_RXN_BD32554
RxCUI2640900
SPL_SET_ID62f39a7c-00df-4519-a8d4-39bbd0a649ed
VUID4042374
Prescribable Synonymadalimumab-adbm Pen 40 MG/0.8 ML Starter Pack - Psoriasis/Uveitis (4 count)
RXNAV_STR{4 (0.8 ML adalimumab-adbm 50 MG/ML Auto-Injector) } Pack
RxNorm Name{4 (0.8 ML adalimumab-adbm 50 MG/ML Auto-Injector) } Pack
RxNorm Synonymadalimumab-adbm Pen 40 MG/0.8 ML Starter Pack - Psoriasis/Uveitis (4 count)
Related queriesInteractions (for RxCUI 2640900)



NDC Properties

NDC Item 00597054544

NDC 90597-0545
NDC 100597-0545-44
NDC Item00597054544
Packaging4 KIT in 1 CARTON (0597-0545-44) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (0597-0540-10) / .8 mL in 1 SYRINGE * 2 PACKET in 1 TRAY / 1 mL in 1 PACKET
BLABLA761058
FDA SPL set id784593
LabelerBoehringer Ingelheim Pharmaceuticals, Inc.
Label typeHUMAN PRESCRIPTION DRUG
Marketing categoryBLA
Marketing effective time low2023-10-01
Marketing statusACTIVE
Related queriesProperties for NDC 9 0597-0545